Oxford Biomedica plc (LON:OXB)

Oxford Biomedica Revenue

In the year 2025, Oxford Biomedica had annual revenue of 168.74M GBP with 31.01% growth. Oxford Biomedica had revenue of 95.52M in the half year ending December 31, 2025, with 105.51% growth.

• Revenue: 168.74M
• Revenue Growth: +31.01%
• P/S Ratio: 4.43
• Revenue / Employee: 172.71K
• Employees: 977
• Market Cap: 747.29M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	168.74M	39.94M	31.01%
Dec 31, 2024	128.80M	39.26M	43.84%
Dec 31, 2023	89.54M	-50.45M	-36.04%
Dec 31, 2022	139.99M	-2.81M	-1.97%
Dec 31, 2021	142.80M	55.07M	62.77%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 22, 2026

Data Sources Report a data error